Phase 2 Schizophrenia Trial, Recruiting (NCT04917302)

Phase 2 Schizophrenia Trial, Recruiting NCT04917302 Sponsor: China Medical University Hospital Condition: Schizophrenia

Printed from Voxsanity (voxsanity.com.au) — NCT04917302 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Schizophrenia

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been officially diagnosed with schizophrenia according to standard psychiatric guidelines (DSM-5)
Your symptoms have not responded well enough to at least two different antipsychotic medications
Your symptoms have been stable (without major changes) for at least 3 months, and your medication doses have stayed the same and will continue unchanged throughout the 12-week study
Your symptom severity meets a minimum score on a standard schizophrenia rating scale (confirm with trial site)
You are willing to take part in the study and have signed a consent form agreeing to participate

Who may not be able to join:

You have a diagnosis of intellectual disability or a problem with alcohol or other substance use, according to standard psychiatric guidelines (DSM-5)
You have a history of epilepsy, a serious head injury, stroke, or other significant brain or medical conditions (besides schizophrenia) that could affect the study
Your routine blood or other lab tests show results that are a cause for medical concern
You are currently pregnant or breastfeeding
You are unable or unwilling to follow the study's requirements and procedures

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 2 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04917302

Sponsor: China Medical University Hospital

Phase: Phase 2

Status: Recruiting

Condition: Schizophrenia

More information: https://clinicaltrials.gov/study/NCT04917302

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been officially diagnosed with schizophrenia according to standard psychiatric guidelines (DSM-5)
Your symptoms have not responded well enough to at least two different antipsychotic medications
Your symptoms have been stable (without major changes) for at least 3 months, and your medication doses have stayed the same and will continue unchanged throughout the 12-week study
Your symptom severity meets a minimum score on a standard schizophrenia rating scale (confirm with trial site)
You are willing to take part in the study and have signed a consent form agreeing to participate

Who may not be able to join:

You have a diagnosis of intellectual disability or a problem with alcohol or other substance use, according to standard psychiatric guidelines (DSM-5)
You have a history of epilepsy, a serious head injury, stroke, or other significant brain or medical conditions (besides schizophrenia) that could affect the study
Your routine blood or other lab tests show results that are a cause for medical concern
You are currently pregnant or breastfeeding
You are unable or unwilling to follow the study's requirements and procedures

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 2 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

China Medical University Hospital

Registry

ClinicalTrials.gov

Start date

13 October 2020

Est. completion

1 November 2026

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Change of Positive and Negative Syndrome Scale (PANSS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov